An alternative synthesis of Azilsartan: an angiotensin II receptor blocker
Journal Title: Current Issues in Pharmacy and Medical Sciences - Year 2015, Vol 28, Issue 2
Abstract
This paper provides a description of an alternative, novel and commercially viable process which has been developed for the preparation of Azilsartan, a pro-drug of Azilsartan medoxomil, an angiotensin II receptor blocker. The present work also provides a primary account of the synthesis and characterization of the novel intermediates (6, 7 & 10) of Azilsartan, with their spectral data.
A comparison of the antioxidant properties of selected edible sprouts of the Legumes family
Germinating seeds of the Legumes family are a natural source of valuable nutrients. The aim of the study was to compare the antioxidant properties of selected edible sprouts from the Legumes family. Lentil and mung bean...
Physical properties and caffeine release from creams prepared with different oils
Caffeine is a methylxanthine typically found in the Coffee Arabica L plant. Generally, caffeine is well-known as a orally administered mild stimulant of the central nervous system. However, for cosmetic purpose, caffeine...
Influence of sterilization on the rheological properties of different types polyacrylic acid gels
The aim of the study was to analyze the influence of sterilization conditions on the rheological properties of gels containing polyacrylic acid derivatives (Carbopols: 974P, Ultrez 10 and Ultrez 20). The gels utilized in...
Characteristics of oral probiotics – a review
Probiotics are a group of microorganisms able to have a positive influence on a host organism when applied in adequate amounts. They are grouped either as: bacteria (mainly Lactobacillus spp and Bifidobacterium) or fungi...
Doxorubicin induces delayed heart and liver mitochondrial depolarisation
The effect of repeated administration of doxorubicin (DOX) on heart and liver morphology, mitochondrial function and redox equilibrium was investigated in rats, contributing in explanation of delayed cardiomyopathy. Male...